International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.
The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.
The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner
Carole Bodin and associate
Pascaline Sagot, who advised on the corporate aspects, with partner
Alexandre Vuchot and associate
Caroline Arrighi-Savoie advising on the regulatory aspects.
The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.